A board-certified medical oncologist, Dr. Liu specializes in lung cancer, cancers of the head and neck, and skin. With advanced training in genomic analysis of cancers and rational drug development the process of identifying new medications based on knowing a biological target Dr. Liu is a strong advocate of genomic testing to identify actionable mutations leading to the most effective, targeted therapies for personalized care. He is the recipient of many teaching and patient care awards.
Dr. Liu has extensive experience conducting and designing clinical trials, serving as the principal investigator for dozens of studies including national trials. An active member of the Developmental Therapeutics Program at Lombardi Comprehensive Cancer Center, Dr. Liu focuses his research on developing novel immunotherapy options for patients with advanced lung and head and neck cancers.
The author of 29 journal articles and 5 book chapters, Dr. Liu has also presented more than 50 abstracts at national meetings. He currently serves as the chief editor for Frontiers of Thoracic Oncology and vice-chair for the MedStar Georgetown University Institutional Review Board, which oversees research and clinical trials.
Dr. Liu's Philosophy of Care
I subscribe to MedStar Georgetown University Hospital's mission, cura personalis caring for the whole person and I am an advocate for my patients. I stress the importance of open communication between physicians and patients and strive to provide my patients with the most advanced care available.
I strongly believe that all patients deserve the opportunity to benefit from the latest cancer research advances, including genomic testing which is becoming increasingly important to identify differences between patients' cancers and guide treatment decisions. I am also committed to conducting research that will contribute to our understanding of cancer and helping future patients.